GOLDMAN SACHS GROUP INC - Dec 31, 2024 Form SCHEDULE 13G Schedule Report for SILEXION THERAPEUTICS CORP (SLXN)

Filing Manager: GOLDMAN SACHS GROUP INC
Reporting Manager: THE GOLDMAN SACHS GROUP, INC.
Security: SILEXION THERAPEUTICS CORP Ordinary Shares, par value $0.0009 per share
Symbol: SLXN
Shares outstanding: 1.7M shares
Disclosed Ownership: 112K shares
Ownership: 6.6%
Form type: SCHEDULE 13G
Date filed: 2/10/2025, 05:31 PM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
THE GOLDMAN SACHS GROUP, INC.	6.6%	112K	0	112K	Name: Sam Prashanth	Attorney-in-fact
GOLDMAN SACHS & CO. LLC	6.6%	112K	0	112K	Name: Sam Prashanth	Attorney-in-fact